Mucormycosis is a potentially fatal fungal infection with high prevalence in poor-resource settings. Besides being an extremely expensive disease to treat, the challenges range from lack of experienced mycologists or mycology department to knowledge and availability of treatment regimes.
PetrikkosGSkiadaALortholaryOet al.Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis2012; 54(Suppl. 1): S23–34.
2.
Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol 2018 Aug 1. doi: 10.1093/mmy/mmy060.
3.
ChakrabartiASinghR. Mucormycosis in India: unique features. Mycoses2014; 57(Suppl. 3): 85–90.
4.
WalshTJSkiadaACornelyOAet al.Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses2014; 57: 2–7.
5.
LacknerMCaramalhoRLass-FlörlC. Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol2014; 9: 683–695.
6.
CallejasCADouglasRG. Fungal rhinosinusitis: what every allergist should know. Clin Exp Allergy2013; 43: 835–849.
7.
KostamoKRichardsonMEerolaEet al.Negative impact of Aspergillus galactomannan and DNA detection in the diagnosis of fungal rhinosinusitis. J Med Microbiol2007; 56: 1322–1327.
8.
DanionFAguilarCCatherinotEet al.Mucormycosis: new developments into a persistently devastating infection. Semin Respir Crit Care Med2015; 36: 692–705.
9.
HamillRJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs2013; 73: 919–934.
10.
DekkersBGJBakkerMvan der ElstKCMet al.Therapeutic drug monitoring of posaconazole: an update. Curr Fungal Infect Rep2016; 10: 51–61.
11.
NichollsRSDuqueSOlayaLAet al.Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world. Parasit Vectors2018; 11: 237–237.
12.
KontoyiannisDPLewisRE. How I treat mucormycosis. Blood2011; 118: 1216–1224.
13.
FujitaMHiranoRMatsumotoTet al.Pilot study of intermittent administration of liposomal amphotericin B for chronic pulmonary aspergillosis. Jpn J Antibiot2014; 67: 205–210.
